537 related articles for article (PubMed ID: 9724117)
1. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
3. Gliosarcoma: a clinical study.
Lutterbach J; Guttenberger R; Pagenstecher A
Radiother Oncol; 2001 Oct; 61(1):57-64. PubMed ID: 11578729
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
5. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
6. A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
Singh G; Mallick S; Sharma V; Joshi N; Purkait S; Jha P; Sharma MC; Suri V; Julka PK; Mahapatra AK; Singh M; Kale SS; Sarkar C
Neuropathology; 2012 Oct; 32(5):534-42. PubMed ID: 22380407
[TBL] [Abstract][Full Text] [Related]
7. Gliosarcoma: a rare variant of glioblastoma multiforme.
Rizvi S; Asghar AH; Mehboob J
J Pak Med Assoc; 2010 Sep; 60(9):773-5. PubMed ID: 21381591
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
9. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma.
Deb P; Sharma MC; Chander B; Mahapatra AK; Sarkar C
Childs Nerv Syst; 2006 Mar; 22(3):314-9. PubMed ID: 16133270
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and treatment of rhabdoid glioblastoma.
Babu R; Hatef J; McLendon RE; Cummings TJ; Sampson JH; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):412-9. PubMed ID: 23641829
[TBL] [Abstract][Full Text] [Related]
11. Gliosarcoma cerebri with a myxoid matrix of the sarcomatous component.
Panayiotides JG; Arapantoni-Dadioti P; Lekka-Katsoulic J; Mariatos P; Delides GS
Rom J Morphol Embryol; 1994; 40(1-2):45-50. PubMed ID: 7640376
[TBL] [Abstract][Full Text] [Related]
12. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
[TBL] [Abstract][Full Text] [Related]
13. Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
Pierscianek D; Ahmadipour Y; Michel A; Rauschenbach L; Darkwah Oppong M; Deuschl C; Kebir S; Wrede KH; Glas M; Stuschke M; Sure U; Jabbarli R
Clin Neurol Neurosurg; 2021 Jan; 200():106348. PubMed ID: 33158630
[TBL] [Abstract][Full Text] [Related]
14. An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.
Pietschmann S; von Bueren AO; Kerber MJ; Baumert BG; Kortmann RD; Müller K
PLoS One; 2015; 10(4):e0121592. PubMed ID: 25860797
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma: clinical experiences and additional information with MR spectroscopy.
Buhl R; Stark AM; Hugo HH; Rohr A; Mehdorn HM
Neurol Res; 2009 Oct; 31(8):873-7. PubMed ID: 19215667
[TBL] [Abstract][Full Text] [Related]
17. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
Sreenan JJ; Prayson RA
Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
[TBL] [Abstract][Full Text] [Related]
18. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
J Neurooncol; 1994; 21(2):177-85. PubMed ID: 7861194
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas.
Nemoto K; Ogawa Y; Matsushita H; Takeda K; Takai Y; Yamada S; Kumabe T
BMC Cancer; 2002; 2():1. PubMed ID: 11818027
[TBL] [Abstract][Full Text] [Related]
20. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS
Int J Radiat Oncol Biol Phys; 1993 May; 26(2):239-44. PubMed ID: 8387988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
